UNII-2EQ5W5403J; 2EQ5W5403J; 2-hydroxy-4-(2-hydroxy-4-methoxy-6-methylbenzoyl)oxy-6-methylbenzoic acid; Evernic acid, pruiss; EINECS 208-658-2; NSC 81164; BRN 2227186; Evernsaure; EVERNICACID; SpecPlus_000646; Oprea1_749224; 3-10-00-01488 (Beilstein Handbook Reference); MLS001049100; DivK1c_006742; REGID_for_CID_10829; SCHEMBL2552354; CHEMBL1484978; CTK8F9707; KBio1_001686; DTXSID20201956; 4-((4-Methoxy-6-methylsalicyloyl)oxy)-6-methylsalicylic acid; HMS2267A10; ZINC517415; NSC81164; BDBM50491952; MFCD00045824; NSC-81164; 2,6-CRESOTIC ACID, 4-METHOXY-, 4-ESTER with 6-METHYL-beta-RESORCYLATE; AKOS015969692; CCG-231001; NCGC00246189-01; SMR000386932; WLN: QR CQ E1 DVOVR BQ F1 DO1; AB00053221-08; Q27190901; 2, 4-methoxy-, 4-ester with 6-methyl-.beta.-resorcylate; 2,6-Cresotic acid, 4-methoxy-, 4-ester with 6-methyl-beta-resorcylic acid (8CI); 2-hydroxy-4-(2-hydroxy-4-methoxy-6-methyl-benzoyl)oxy-6-methyl-benzoic acid; 2-Hydroxy-4-[(2-hydroxy-4-methoxy-6-methylbenzoyl)oxy]-6-methylbenzoic acid; Benzoic acid, 2-hydroxy-4-[(2-hydroxy-4-methoxy-6-methylbenzoyl)oxy]-6-methyl-